Lin, Hui-Min Diana http://orcid.org/0000-0001-8397-0413
Lai, Chao-Lun
Dong, Yaa-Hui
Tu, Yu-Kang
Chan, K. Arnold http://orcid.org/0000-0001-8161-1986
Suissa, Samy
Funding for this research was provided by:
National Taiwan University Hospital, Hsin-Chu Branch (105-HCH016, 105-HCH003)
Article History
First Online: 25 June 2019
Compliance with Ethical Standards
:
: The study was approved by the Institutional Review Board of the National Taiwan University Hospital Hsin-Chu Branch (approval document 104-009-E) and individual authorization by study subjects was waived for the use of anonymous data.
: K. Arnold Chan is the principal investigator for several industry-sponsored studies and Hui-Min Diana Lin is employed through one of the research contracts, none of them are related to this report. Chao-Lun Lai reports receiving lecture fees from Astra-Zeneca, Pfizer, Bayer AG, Novartis, Actelion, Boehringer Ingelheim, Excelsior, Sanofi-Aventis, MSD, Tanabe, Daiichi-Sankyo, and Abbott. Samy Suissa has received research funding, participated in advisory board meetings or as speaker for Bayer, BoehringerâIngelheim, and Bristol-Myers-Squibb. Yaa-Hui Dong and Yu-Kang Tu have no conflicts of interest to disclose.
: This work was supported by Grants from the National Taiwan University Hospital, Hsin-Chu Branch (105-HCH016 and 105-HCH003).